Drospirenone

屈螺酮

Report date: 2025/11/27 15:35:27

Base Information

Drug NameDrospirenone
Drug Alias Namedrospirenonum曲螺酮drospirenonaSlyndLPRI-CF113 +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsAndrogen Receptor antagonistsMineralocorticoid receptor antagonists
TargetsAndrogen ReceptorMineralocorticoid receptorProgesterone receptor
Therapy Area/IndicationsVasomotor symptomContraceptionDepression +[14] 
Global Approved IndicationsContraception
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2019/05/23
Country/TerritoryCanadaUnited StatesThailand +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesInsud PharmaUniversitas PadjadjaranChulalongkorn University +[4] 
Inactive CompaniesCairo UniversityUniversity Of RochesterInstituto Do Coracao +[11] 
Active IndicationsContraceptionStomatitis, Aphthous
Inactive IndicationsVasomotor symptomDepressionDrug-Related Side Effects and Adverse Reactions +[12] 

Other Information

ATC CodeG03AC10
Related LinksWikipediaDrugBankKEGG